Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-24-255932
Filing Date
2024-11-12
Accepted
2024-11-12 16:06:34
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-1 d826831ds1.htm S-1 303006
2 EX-5.1 d826831dex51.htm EX-5.1 17043
3 EX-21 d826831dex21.htm EX-21 6319
4 EX-23.1 d826831dex231.htm EX-23.1 1476
5 EX-FILING FEES d826831dexfilingfees.htm EX-FILING FEES 32440
6 GRAPHIC g826831g1105120010405.jpg GRAPHIC 7082
7 GRAPHIC g826831g46f45.jpg GRAPHIC 4147
8 GRAPHIC g826831g67t63.jpg GRAPHIC 2397
  Complete submission text file 0001193125-24-255932.txt   380505
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-283150 | Film No.: 241448034
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)